Patents by Inventor Maheshkumar Parasmal SONI
Maheshkumar Parasmal SONI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240115523Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.Type: ApplicationFiled: November 21, 2023Publication date: April 11, 2024Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Praveen Kumar SRIVASTAVA, Prashant KANE, Subhas Balaram BHOWMICK
-
Patent number: 11865089Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.Type: GrantFiled: October 18, 2021Date of Patent: January 9, 2024Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth Kumar, Maheshkumar Parasmal Soni, Praveen Kumar Srivastava, Prashant Kane, Subhas Balaram Bhowmick
-
Publication number: 20230140586Abstract: A parenteral dosage form having an infusion container filled with an aqueous solution in volumes ranging from 40 ml to 500 ml comprising 1 mg/ml to 2 mg/ml of carboplatin, wherein the solution contains known impurity of 1, 1-cyclobutanedicarboxylic acid in an amount of not more than 1.0% by weight of carboplatin and the solution remains physically stable when stored at room temperature.Type: ApplicationFiled: August 30, 2019Publication date: May 4, 2023Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Subhas Balaram BHOWMICK, Prashant KANE
-
Publication number: 20220233403Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: January 3, 2022Publication date: July 28, 2022Inventors: Samarth Kumar, Maheshkumar Parasmal Soni, Nishit Patel, Prashant Kane, Subhas Balaram Bhowmick
-
Patent number: 11273100Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.Type: GrantFiled: February 20, 2020Date of Patent: March 15, 2022Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth Kumar, Maheshkumar Parasmal Soni, Nishit Patel, Prashant Kane, Subhas Balaram Bhowmick
-
Publication number: 20220054434Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.Type: ApplicationFiled: October 18, 2021Publication date: February 24, 2022Inventors: Samarth Kumar, Maheshkumar Parasmal Soni, Praveen Kumar Srivastava, Prashant Kane, Subhas Balaram Bhowmick
-
Patent number: 11246801Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.Type: GrantFiled: May 4, 2020Date of Patent: February 15, 2022Assignee: Sun Pharmaceutical Industries LimitedInventors: Samarth Kumar, Maheshkumar Parasmal Soni, Nishit Patel, Prashant Kane, Subhas Balaram Bhowmick
-
Publication number: 20210401669Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: May 4, 2020Publication date: December 30, 2021Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
-
Patent number: 11197838Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.Type: GrantFiled: August 10, 2020Date of Patent: December 14, 2021Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth Kumar, Maheshkumar Parasmal Soni, Praveen Kumar Srivastava, Prashant Kane, Subhas Balaram Bhowmick
-
Publication number: 20210369565Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof.Type: ApplicationFiled: February 20, 2020Publication date: December 2, 2021Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
-
Publication number: 20210038539Abstract: The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.Type: ApplicationFiled: August 10, 2020Publication date: February 11, 2021Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Praveen Kumar SRIVASTAVA, Prashant KANE, Subhas Balaram BHOWMICK
-
Publication number: 20200315913Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: May 4, 2020Publication date: October 8, 2020Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
-
Publication number: 20200268606Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof.Type: ApplicationFiled: February 20, 2020Publication date: August 27, 2020Inventors: Samarth KUMAR, Maheshkumar Parasmal SONI, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
-
Patent number: 9757352Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: GrantFiled: April 18, 2017Date of Patent: September 12, 2017Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai Rana, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Maheshkumar Parasmal Soni, Milan Mohanbhai Vasoya, Samarth Kumar
-
Publication number: 20170216243Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: ApplicationFiled: April 18, 2017Publication date: August 3, 2017Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai RANA, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Maheshkumar Parasmal SONI, Milan Mohanbhai VASOYA, Samarth KUMAR
-
Patent number: 9642828Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: GrantFiled: September 21, 2015Date of Patent: May 9, 2017Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai Rana, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Maheshkumar Parasmal Soni, Milan Mohanbhai Vasoya, Samarth Kumar
-
Publication number: 20160081972Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: ApplicationFiled: September 21, 2015Publication date: March 24, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai RANA, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Maheshkumar Parasmal SONI, Milan Mohanbhai VASOYA, Samarth KUMAR